13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Research home > Beat Cancer Project search > Towards a new genomic classification of risk for patients with chronic myeloid leukaemia

    Towards a new genomic classification of risk for patients with chronic myeloid leukaemia

    Associate Professor Susan Branford
    • Donor Funding: $80,000
    • Cancer Type: Blood cancers
    • Cancer Stage: Treatment
    • Funded in: 2019
    • Associate Professor Susan Branford
      University of South Australia

    Survival for patients with chronic myeloid leukaemia has improved but a proportion fail therapy. Failure is related to poorly defined genetic
    abnormalities that may already be present at diagnosis. We will detect these abnormalities using state-of-the art sequencing technologies.

    Our aim is to develop new ways to stratify patients at diagnosis according to their risk of treatment failure. These patients may receive more potent
    drugs to reduce the risk of treatment failure and death.



  • Apply for funding

    Apply for funding

    Find out more about applications for funding.

  • Cancer statistics

    Cancer statistics

    Access the latest cancer statistics for South Australia

  • Clinical trials

    Clinical trials

    Access the list of current clinical trials taking place in South Australia.